NMPA Approval

Insulin Degludec and Insulin Aspart Injection

Approval Number

S20191007

Registration Date

June 27, 2019

Previous Approval Numbers

S20190028

Drug Information

Generic Name

德谷门冬双胰岛素注射液

Trade Name

诺和佳

Brand Name

诺和灵R笔芯

Dosage Form

注射剂

Strength

3ml:300单位(畅充)

Drug Type

生物制品

Registration Date

June 27, 2019

Expiry Date

May 20, 2024

Company Address

Novo Alle,DK-2880 Bagsvaerd,Denmark

Company Address

Novo Alle,DK-2880 Bagsvaerd,Denmark

Empowering clinical research with data-driven insights and AI-powered tools.

德谷门冬双胰岛素注射液 - NMPA 批准文号 | MedPath